Bionas

Bionas GmbH was a German biotechnology company that specialized in the development of label-free, cell-based assay systems for real-time monitoring of cellular metabolism. The company's flagship technology, the Bionas 2500 analyzing system, enabled the simultaneous measurement of oxygen consumption, extracellular acidification, and cell adhesion in living cells. This platform was widely utilized in drug discovery, toxicology, and metabolic research to provide continuous insights into the physiological state of cells under various chemical or environmental stressors. In 2011, the company's technology and assets were acquired by Nanion Technologies, which integrated the Bionas system into its portfolio of analytical tools for life science research.